Industry news
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 32 KB
## New trial of Rezulin Warner-Lambert Co. will initiate a long-term study to investigate the potential of Rezulin (troglitazone) to delay or prevent the progression of impaired glucose tolerance (IGT).